← Leaderboards
Anuja Dokras-Jagasia
University Of Iowa
$4,413,751
Attributed
$4,413,751
Total exposure
11
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $606.1K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,413,751 · 11
By mechanism
R01$3,807,465 · 2
K08$294,030 · 1
R03$162,500 · 1
M01$81,756 · 6
R13$68,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Iowa
Same institution · by research overlap
- George J Weiner$29,916,936
- Patricia Winokur$49,027,551
- Katherine Mathews$11,391,241
- Kevin P. Campbell$16,898,890
- Mark Anthony Yorek$7,990,158
Others in their field
Top investigators on “Woman”
- Chanza Baytop · Westat, Inc.$271,217,917
- Lawrence Corey · Fred Hutchinson Cancer Center$252,110,127
- Wafaa M. El-Sadr · Columbia University Health Sciences$232,152,340
- Myron S Cohen · Family Health International$208,921,087
- Barbara Driver · Westat, Inc.$190,429,693
- Judith S. Currier · University Of California Los Angeles$149,317,678
Research focus
WomanInsulin ResistancePolycystic Ovary SyndromeAffectMetabolicAndrogensReproductiveRisk FactorsHyperandrogenismPhenotypeCardiovascular DiseasesHirsutismDyslipidemiasNon-Insulin-Dependent Diabetes MellitusPharmaceutical PreparationsInsulinMetabolic SyndromeMorbidity - Disease RateGuidelinesMedicalInternationalPhysiciansRaceDiabetes Mellitus
Grant awards (27)
Resistant starch treatment of polycystic ovary syndrome: impact on cardiometabolic dysfunction and the gut microbiome$476,129
R01 · FY2025 · HL · contact PI
Androgen Excess Polycystic Ovary Syndrome Society Meeting$10,000
R13 · FY2025 · HD · contact PI
Resistant starch treatment of polycystic ovary syndrome: impact on cardiometabolic dysfunction and the gut microbiome$522,579
R01 · FY2024 · HL · contact PI
Androgen Excess Polycystic Ovary Syndrome Society Meeting$10,000
R13 · FY2024 · HD · contact PI
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome$81,250
R03 · FY2023 · HD · contact PI
Androgen Excess Polycystic Ovary Syndrome Society Meeting$10,000
R13 · FY2023 · HD · contact PI
Use of novel 11-oxygenated androgens to improve diagnostic accuracy and therapeutics in polycystic ovary syndrome$81,250
R03 · FY2022 · HD · contact PI
Androgen Excess Polycystic Ovary Syndrome Society Meeting$10,000
R13 · FY2022 · HD · contact PI
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome$506,874
R01 · FY2021 · HD · contact PI
Androgen Excess Polycystic Ovary Syndrome Society Meeting$10,000
R13 · FY2021 · HD · contact PI
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome$548,811
R01 · FY2020 · HD · contact PI
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome$568,991
R01 · FY2019 · HD · contact PI
Androgen Excess Polycystic Ovary Syndrome Society Meeting$6,000
R13 · FY2019 · HD · contact PI
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome$584,007
R01 · FY2018 · HD · contact PI
Androgen Excess Polycystic Ovary Syndrome Society Meeting$6,000
R13 · FY2018 · HD · contact PI
The COMET-PCOS trial - Comparing the effects of Oral Contraceptive Pills versus Metformin in the medical management of overweight/obese women with Polycystic Ovary Syndrome$600,074
R01 · FY2017 · HD · contact PI
Androgen Excess Polycystic Ovary Syndrome Society Meeting$6,000
R13 · FY2017 · HD · contact PI
DIAGNOSTIC MARKERS FOR EARLY DETECTION AND TREATMENT OF PRETERM PREGNANCIES$36,227
M01 · FY2007 · RR · contact PI
CARDIOVASCULAR RISK FACTORS IN WOMEN WITH PCOS$10,039
M01 · FY2007 · RR · contact PI
DIAGNOSTIC MARKERS FOR EARLY DETECTION AND TREATMENT OF PRETERM PREGNANCIES$8,934
M01 · FY2006 · RR · contact PI
POLYCYSTIC OVARY SYNDROME$2,978
M01 · FY2006 · RR · contact PI
CARDIOVASCULAR RISK FACTORS IN WOMEN WITH PCOS$1,655
M01 · FY2006 · RR · contact PI
POLYCYSTIC OVARY SYNDROME$8,093
M01 · FY2005 · RR
Regulation of maspin in placental development$98,010
K08 · FY2004 · HD
Polycystic Ovary Syndrome$13,830
M01 · FY2004 · RR
Regulation of maspin in placental development$98,010
K08 · FY2003 · HD
Regulation of maspin in placental development$98,010
K08 · FY2002 · HD